Correction: Intermittent enzyme replacement therapy prevents Neu1 deficiency

Reversal of neuroinflammation in novel GS model mice by single i.c.v. administration of CHO-derived rhCTSA precursor protein

“…replacement of the recombinant human GLB1 produced by a CHO cell line. 37,38 Stijn et al have shown that i.c.v. injection of recombinant arylsulfatase A (ASA) improves walking function in ASA-deficient mice.…”